Area of research
Cancer Research · Oncology
Research interest
Research focused on Breast cancer and Carboplatin, with related work in Pathological, Chemotherapy, Apocrine. Notable publications include 'Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis', 'Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial', and 'Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative...'.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer